CClinicalTrials.gg
Status unknownNCT02672618Updated Feb 3, 2016

Clinical Research to Explore Manifestations of Heart Failure Using Infrared Thermal Imaging Technology

An observational study in Heart Failure,Congestive, sponsored by Jing Huang. Status unknown at 4 sites in China. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-02-03.

Sponsored by Jing Huang · Observational

The sponsor has not verified this record recently (last verified Feb 2016), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The purpose of this study is to explore manifestations of Heart Failure Using Infrared Thermal Imaging Technology.

Read the detailed description

Temperature is a vital and useful indicator for various diseases.Infrared thermal imaging (IRTI) allows the temperature representation of the body surface by thermal distribution, where it depends on the complex relationships defining the heat exchange processes between skin tissue, inner tissue, local vasculature, and metabolic activity.

The decrease in cardiac output in heart failure activate a series of compensatory adaption that are intended to maintain cardiovascular homeostasis. One of most important adaptation is activation of sympathetic nervous system, which could cause peripheral cutaneous vasoconstriction and decrease the skim temperature. Hence, the skim temperature of heart failure would be lower than health people,but which could not discovery by eye. The investigators hypothesize that IRTI could evaluate heart failure by the imaging of temperature distribution in the face on early stages.The aim of this study is to determine the effectiveness of infrared thermal imaging in evaluating heart failure.

02

Conditions studied

  • Heart Failure,Congestive

Browse trials for

Keywords

  • heart failure
  • infrared thermal imaging
03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's planned enrollment of 200 is close to the median of 200 across 1,679 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

Jing Huang is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Heart failure patients included in this study had been definitively diagnosed as having with Echocardiography. The healthy volunteer group matched the HF group in number, age, and gender.

Inclusion criteria

  1. Willing to participate in the trial and sign the informed consent form
  2. Aged: 18-85 years
  3. Was diagnosed as heart failure
  4. There is no trauma, infection, biopsy or puncture, hemorrhage and tumor in the corresponding detection site (face)
  5. There is no skin disease, heart, liver, kidney, gastrointestinal tract, hematopoietic system and mental, neurological has no serious diseases

Exclusion criteria

Exclusion Criteria:

  1. Fever causes by any reasons, temperature higher than 37.4℃
  2. Infection
  3. Renal failure
  4. Cerebrovascular diseases
  5. Moderate anemia or more
  6. Not willing to participate in clinical trials
05

Study design

Time perspective
Cross-sectional
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • chronic heart failure

    18-85years old,having symptoms of heart failure,New York Heart Association(NYHA) class II or above American College of Cardiology/American Heart Association(ACC/AHA) class B, C, including hypertensive heart disease, rheumatic heart disease, ischemic cardiomyopathy and idiopathic cardiomyopathy

  • normalCardiac function

    18-85years old,no symptoms of heart failure,NYHA class I or above ACC/AHA class A, including controled hypertension,stability coronary heart disease and rheumatic heart disease

  • healthy volunteers

    18-85years old,Without basic cardiovascular diseases

06

What researchers measure

Primary outcomes

  1. Surface temperature (℃)of face and hand measured by Infrared (IR) camera

    Time frame: up to 12 months

Secondary outcomes

  1. LVEF(left ventricular ejection fraction)

    Time frame: up to 12 months

  2. proBNP(pro Brain Natriuretic Peptide)

    Time frame: up to 12 months

  3. catecholamine levels

    Time frame: up to 12 months

  4. Entropy of thermal image

    Entropy of thermal image: show chaos degree of skim temperature distribution.

    Time frame: up to 12 months

07

Study locations

1 of 4 sites recruiting
  • The 2nd Affiliated Hospital of Chongqing Medical University
    Chongqing, Chongqing 400010, China
    • Jing Huang, MD · Contact · huangjing@cqmu.edu.cn · 0086-13508312022
    • Jing Huang, MD · Principal investigator
    Recruiting
  • 3Rd People'S Hospital of Chengdu
    Chengdu, Sichuan, China
    • Wang chunbin · Contact
    Not yet recruiting
  • The First Affiliated Hospital of Sichuan Medical University:
    Luzhou, Sichuan, China
    • Jiang feng · Contact
    Not yet recruiting
  • The First Affiliated Hospital of Chongqing Medical University:
    Chongqing, China
    • Guo rui · Contact
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02672618
Lead sponsor
Jing Huang
Responsible party
Jing Huang (professor,vice director, The Second Affiliated Hospital of Chongqing Medical University) — Sponsor-investigator
First posted
Feb 3, 2016
Start date
Nov 2015
Primary completion
Jan 2017 (estimated)
Completion
Jun 2017 (estimated)
Last update
Feb 3, 2016

Study contacts

huang jing
Contact
huangjing@cqmu.edu.cn
hang jing
study director · Chongqing Medical University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion